Companies Dominating the Autotransfusion Devices Landscape
- ProCell Surgical Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- BD (Becton, Dickinson and Company)
- Fresenius SE & Co. KGaA
- Medtronic
- Beijing Jingjing Medical Equipment Co., Ltd.
- Haematonics Corporation
- LivaNova PLC
- Zimmer Biomet
- SARSTEDT AG & Co. KG
- Gen World Medical Devices
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Autotransfusion Devices Market in 2025 is estimated at USD 300.89 million.
The global market size was more than USD 285.15 million in 2024 and is anticipated to grow at a CAGR of over 6.9%, reaching USD 678.87 million revenue by 2037.
Asia Pacific is expected to register highest growth rate by 2037, fueled by entry of new industry players and increasing surgeries.
The major players in the market include ProCell Surgical Inc, .BD (Becton, Dickinson and Company), Fresenius SE & Co. KGaA, Medtronic, Beijing Jingjing Medical Equipment Co., Ltd., Haematonics Corporation, LivaNova PLC, Zimmer Biomet, SARSTEDT AG & Co. KG, Gen World Medical Devices.
